| Year |
Citation |
Score |
| 2020 |
Halvorsen M, Huh R, Oskolkov N, Wen J, Netotea S, Giusti-Rodriguez P, Karlsson R, Bryois J, Nystedt B, Ameur A, Kähler AK, Ancalade N, Farrell M, Crowley JJ, Li Y, et al. Increased burden of ultra-rare structural variants localizing to boundaries of topologically associated domains in schizophrenia. Nature Communications. 11: 1842. PMID 32296054 DOI: 10.1038/S41467-020-15707-W |
0.336 |
|
| 2019 |
Farrell M, Lichtenstein M, Crowley J, Filmyer D, Lázaro-Muñoz G, Shaughnessy R, Mackenzie IR, Hirsch-Reinshagen V, Stowe R, Evans J, Berg J, Szatkiewicz J, Josiassen R, Sullivan PF. THE GENOMICS OF HIGHLY TREATMENT RESISTANT SCHIZOPHRENIA European Neuropsychopharmacology. 29: S1006-S1007. DOI: 10.1016/J.Euroneuro.2017.08.401 |
0.334 |
|
| 2016 |
Farrell MS, McCorvy JD, Huang XP, Urban DJ, White KL, Giguere PM, Doak AK, Bernstein AI, Stout KA, Park SM, Rodriguiz RM, Gray BW, Hyatt WS, Norwood AP, Webster KA, et al. In Vitro and In Vivo Characterization of the Alkaloid Nuciferine. Plos One. 11: e0150602. PMID 26963248 DOI: 10.1371/Journal.Pone.0150602 |
0.599 |
|
| 2015 |
Huang XP, Karpiak J, Kroeze WK, Zhu H, Chen X, Moy SS, Saddoris KA, Nikolova VD, Farrell MS, Wang S, Mangano TJ, Deshpande DA, Jiang A, Penn RB, Jin J, et al. Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65. Nature. PMID 26550826 DOI: 10.1038/Nature15699 |
0.431 |
|
| 2015 |
Urban DJ, Zhu H, Marcinkiewcz CA, Michaelides M, Oshibuchi H, Rhea D, Aryal DK, Farrell MS, Lowery-Gionta E, Olsen RH, Wetsel WC, Kash TL, Hurd YL, Tecott LH, Roth BL. Elucidation of the Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26383016 DOI: 10.1038/Npp.2015.293 |
0.694 |
|
| 2015 |
Farrell MS, Werge T, Sklar P, Owen MJ, Ophoff RA, O'Donovan MC, Corvin A, Cichon S, Sullivan PF. Evaluating historical candidate genes for schizophrenia. Molecular Psychiatry. 20: 555-62. PMID 25754081 DOI: 10.1038/Mp.2015.16 |
0.318 |
|
| 2013 |
Farrell MS, Pei Y, Wan Y, Yadav PN, Daigle TL, Urban DJ, Lee HM, Sciaky N, Simmons A, Nonneman RJ, Huang XP, Hufeisen SJ, Guettier JM, Moy SS, Wess J, et al. A Gαs DREADD mouse for selective modulation of cAMP production in striatopallidal neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 854-62. PMID 23303063 DOI: 10.1038/Npp.2012.251 |
0.688 |
|
| 2013 |
Farrell MS, Roth BL. Pharmacosynthetics: Reimagining the pharmacogenetic approach. Brain Research. 1511: 6-20. PMID 23063887 DOI: 10.1016/j.brainres.2012.09.043 |
0.474 |
|
| 2011 |
Allen JA, Yadav PN, Setola V, Farrell M, Roth BL. Schizophrenia risk gene CAV1 is both pro-psychotic and required for atypical antipsychotic drug actions in vivo. Translational Psychiatry. 1: e33. PMID 22832607 DOI: 10.1038/Tp.2011.35 |
0.7 |
|
| 2011 |
Yadav PN, Kroeze WK, Farrell MS, Roth BL. Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo. The Journal of Pharmacology and Experimental Therapeutics. 339: 99-105. PMID 21737536 DOI: 10.1124/jpet.111.183780 |
0.506 |
|
| 2011 |
Yadav PN, Abbas AI, Farrell MS, Setola V, Sciaky N, Huang XP, Kroeze WK, Crawford LK, Piel DA, Keiser MJ, Irwin JJ, Shoichet BK, Deneris ES, Gingrich J, Beck SG, et al. The presynaptic component of the serotonergic system is required for clozapine's efficacy. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 638-51. PMID 21048700 DOI: 10.1038/Npp.2010.195 |
0.699 |
|
| 2010 |
Dong S, Allen JA, Farrell M, Roth BL. A chemical-genetic approach for precise spatio-temporal control of cellular signaling. Molecular Biosystems. 6: 1376-80. PMID 20532295 DOI: 10.1039/C002568M |
0.692 |
|
| 2010 |
Abbas AI, Urban DJ, Jensen NH, Farrell MS, Kroeze WK, Mieczkowski P, Wang Z, Roth BL. Assessing serotonin receptor mRNA editing frequency by a novel ultra high-throughput sequencing method. Nucleic Acids Research. 38: e118. PMID 20185571 DOI: 10.1093/Nar/Gkq107 |
0.675 |
|
| 2010 |
Farrell M, Roth BL. Allosteric antipsychotics: m4 muscarinic potentiators as novel treatments for schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 851-2. PMID 20145632 DOI: 10.1038/Npp.2009.206 |
0.475 |
|
| 2008 |
Farrell MS, Gilmore K, Raffa RB, Walker EA. Behavioral characterization of serotonergic activation in the flatworm Planaria. Behavioural Pharmacology. 19: 177-82. PMID 18469535 DOI: 10.1097/FBP.0b013e3282fe885e |
0.322 |
|
| Show low-probability matches. |